UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 152

Sortiert nach

Quality of life during chemotherapy in lung cancer patients: results across different treatment lines

British journal of cancer, 2013-10, Vol.109 (9), p.2301-2308

2013

Volltextzugriff (PDF)

Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants

Journal of breath research, 2012-09, Vol.6 (3), p.036008-1-21

2012

Volltextzugriff (PDF)

CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer

Journal of clinical pathology, 2004-09, Vol.57 (9), p.965-969

2004

Volltextzugriff (PDF)

Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172 210 men and women: a prospective 19-year follow-up study

Annals of oncology, 2009-06, Vol.20 (6), p.1113-1120

2009

Volltextzugriff (PDF)

Small steps of improvement in small-cell lung cancer (SCLC) within two decades: A comprehensive analysis of 484 patients

Lung cancer (Amsterdam, Netherlands), 2014-05, Vol.84 (2), p.168-174

2014

Volltextzugriff (PDF)

The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28 000 older Austrian women

Annals of oncology, 2007-11, Vol.18 (11), p.1893-1897

2007

Volltextzugriff (PDF)

Overcoming resistance to first generation EGFR TKIs with cetuximab in combination with chemotherapy in an EGFR mutated advanced stage NSCLC patient

Lung cancer (Amsterdam, Netherlands), 2014-03, Vol.83 (3), p.408-410

2014

Volltextzugriff (PDF)

Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II, IIIA and IIIB (TAX-AT 1.203 Trial)

Lung cancer (Amsterdam, Netherlands), 2014-09, Vol.85 (3), p.395-400

2014

Volltextzugriff (PDF)

Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society

Pneumologie (Stuttgart, Germany), 2011-01, Vol.65 (1), p.39

2011

Volltextzugriff (PDF)

Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis

Journal of clinical pathology, 2003-10, Vol.56 (10), p.736-741

2003

Volltextzugriff (PDF)

Biweekly Oxaliplatin and Irinotecan Chemotherapy in Advanced Gastric Cancer. A First-line Multicenter Phase II Trial of the Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT)

Anticancer research, 2008-09, Vol.28 (5B), p.2901-2905

2008

Volltextzugriff (PDF)

Biomarkers in non-small cell lung cancer prevention

European journal of cancer prevention, 2004-10, Vol.13 (5), p.425-436

2004

Volltextzugriff (PDF)

Low incidence of mutations in EGFR kinase domain in Caucasian patients with head and neck squamous cell carcinoma

European journal of cancer (1990), 2006, Vol.42 (1), p.109-111

2006

Volltextzugriff (PDF)

CD44 isoforms are differentially regulated in plasma cell dyscrasias and CD44v9 represents a new independent prognostic parameter in multiple myeloma

Leukemia research, 2001-12, Vol.25 (12), p.1051-1057

2001

Volltextzugriff (PDF)

Changing paradigms in clinical trials

Memo - Magazine of European medical oncology, 2010-04, Vol.3 (1), p.1-2

Hilbe, W.

2010

Volltextzugriff (PDF)

Increased CD133 expression in bone marrow of myelodysplastic syndromes

Leukemia research, 2005-09, Vol.29 (9), p.995-1001

2005

Volltextzugriff (PDF)

Oncology in 2010 – small steps towards personalized medicine with special focus on elderly cancer patients

Memo - Magazine of European medical oncology, 2010-12, Vol.3 (4), p.153-154

Hilbe, W.

2010

Volltextzugriff (PDF)

9158 A phase III study of erlotinib as maintenance therapy in NSCLC to delay progression following first-line chemotherapy (SATURN)

European journal of cancer supplements, 2009, Vol.7 (2), p.553-553

2009

Volltextzugriff (PDF)

22LBA Overall survival analyses from the SATURN phase III placebo-controlled study of erlotinib as first-line maintenance therapy in advanced non-small-cell lung cancer (NSCLC)

European journal of cancer supplements, 2009, Vol.7 (3), p.13-13

2009

Volltextzugriff (PDF)

P68 Proteomic changes in colorectal cancer cell lines in response to sorafenib treatment

European journal of cancer supplements, 2009, Vol.7 (4), p.34-34

2009

Volltextzugriff (PDF)

A randomized study comparing interferon (IFNα) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML)

Leukemia research, 2003-05, Vol.27 (5), p.405-411

2003

Volltextzugriff (PDF)

Unusual adverse events following peripheral blood stem cell (PBSC) mobilisation using granulocyte colony stimulating factor (G-CSF) in healthy donors

Bone marrow transplantation (Basingstoke), 2000-10, Vol.26 (7), p.811-813

2000

Volltextzugriff (PDF)

178P - Tumor Endothelial Markers (TEMS) as Prognostic and Predictive Markers in Non-Small Cell Lung Cancer (NSCLC)

Annals of oncology, 2012-09, Vol.23, p.ix76-ix76

2012

Volltextzugriff (PDF)

Tumor Endothelial Markers (TEMS) as Prognostic and Predictive Markers in Non-Small Cell Lung Cancer (NSCLC)

Annals of oncology, 2012-09, Vol.23, p.ix76

2012

Volltextzugriff (PDF)

1 – 25 von 152

Suche als RSS-Feed

Aktive Filter

PublikationsformBücher

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(125)

Publikationsform

Artikel
(134)
Buchkapitel
(17)
Reviews
(1)

Sprache

Englisch
(135)
Deutsch
(17)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quality of life during chemotherapy in lung cancer patients: results across different treatment lines

Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants

CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer

Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172 210 men and women: a prospective 19-year follow-up study

Small steps of improvement in small-cell lung cancer (SCLC) within two decades: A comprehensive analysis of 484 patients

The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28 000 older Austrian women

Overcoming resistance to first generation EGFR TKIs with cetuximab in combination with chemotherapy in an EGFR mutated advanced stage NSCLC patient

Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II, IIIA and IIIB (TAX-AT 1.203 Trial)

Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society

Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

Biweekly Oxaliplatin and Irinotecan Chemotherapy in Advanced Gastric Cancer. A First-line Multicenter Phase II Trial of the Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT)

Biomarkers in non-small cell lung cancer prevention

Low incidence of mutations in EGFR kinase domain in Caucasian patients with head and neck squamous cell carcinoma

CD44 isoforms are differentially regulated in plasma cell dyscrasias and CD44v9 represents a new independent prognostic parameter in multiple myeloma

Changing paradigms in clinical trials

Increased CD133 expression in bone marrow of myelodysplastic syndromes

Oncology in 2010 – small steps towards personalized medicine with special focus on elderly cancer patients

9158 A phase III study of erlotinib as maintenance therapy in NSCLC to delay progression following first-line chemotherapy (SATURN)

22LBA Overall survival analyses from the SATURN phase III placebo-controlled study of erlotinib as first-line maintenance therapy in advanced non-small-cell lung cancer (NSCLC)

P68 Proteomic changes in colorectal cancer cell lines in response to sorafenib treatment

A randomized study comparing interferon (IFNα) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML)

Unusual adverse events following peripheral blood stem cell (PBSC) mobilisation using granulocyte colony stimulating factor (G-CSF) in healthy donors

178P - Tumor Endothelial Markers (TEMS) as Prognostic and Predictive Markers in Non-Small Cell Lung Cancer (NSCLC)

Tumor Endothelial Markers (TEMS) as Prognostic and Predictive Markers in Non-Small Cell Lung Cancer (NSCLC)

Aktive Filter

Suchergebnisse filtern